- CEO
- Sanjaybhai Yashawantrao Marathe
- Full Time Employees
- 99
- Sector
- Process industries
- Industry
- Chemicals: major diversified
- Address
- 330, Trivia Complex Ankleshwar GU India 390007
- IPO Date
- Mar 28, 2017
- Business
- Chemcrux Enterprises Limited manufactures specialty chemical intermediates for pharmaceuticals, dyes and pigments industries through advanced processes including high pressure oxidation, nitration, chlorosulphonation and amidation. The company produces a diverse range of products such as 2-chloro benzoic acid, 3-chloro benzoic acid, 4-chloro benzoic acid, 3-nitro benzoic acid, 4-nitro benzoic acid, 3-nitro salicylic acid, 5-nitro salicylic acid, various dichloro benzoic acids including 2,4-dichloro benzoic acid, 2,3-dichloro benzoic acid and 2,6-dichloro benzoic acid, 4-chloro 3-nitro benzoic acid, 2-chloro 5-nitro benzoic acid, 2-chloro 3-nitro benzoic acid, lasamide, aceturic acid, arabonic acid sodium salt, 4-chloro benzoic acid-3-sulfonamide, BPEA sulfonamide, para chloro benzoyl chloride, ortho chloro benzoyl chloride, 2,4-dichloro benzoyl chloride and 2,3-dichloro benzoyl chloride. Founded in 1983 and headquartered in Vadodara, Gujarat, India, Chemcrux operates primarily from facilities in Ankleshwar, Gujarat, serving multinational pharmaceutical organizations in India and exporting to various countries worldwide. In 2025, the company acquired an additional 50% equity stake in Kalichem Private Limited, converting it into a wholly owned subsidiary effective February 27 and ceasing the prior joint venture structure. It also entered into an exclusive purchase and marketing agreement with Deepak Nitrite Limited for para nitro benzoic acid and a strategic collaboration with Deepak Nitrite to enhance supply chain efficiency. Chemcrux maintains ISO 9001:2008 and ISO 14001:2004 certifications, focusing on custom synthesis for active pharmaceutical ingredients, dyes and pigments sectors.